Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis

Research output: Contribution to journalArticle

Authors

  • Emmanuel Karouzakis
  • Christoph Kolling
  • Steffen Gay
  • Caroline Ospelt

Colleges, School and Institutes

External organisations

  • Schulthess Clinic
  • University Hospitals Birmingham NHS Trust
  • Center of Experimental Rheumatology, Department of Rheumatology, University of Zurich
  • Sandwell and West Birmingham Hospitals NHS Trust

Abstract

DNA methylation is an important epigenetic modification that is known to be altered in rheumatoid arthritis synovial fibroblasts (RASF). Here, we compared the status of promoter DNA methylation of SF from patients with very early RA with SF from patients with resolving arthritis, fully established RA and from non-arthritic patients. DNA was hybridized to Infinium Human methylation 450k and 850k arrays and differential methylated genes and pathways were identified. We could identify a significant number of CpG sites that differed between the SF of different disease stages, showing that epigenetic changes in SF occur early in RA development. Principal component analysis confirmed that the different groups of SF were separated according to their DNA methylation state. Furthermore, pathway analysis showed that important functional pathways were altered in both very early and late RASF. By focusing our analysis on CpG sites in CpG islands within promoters, we identified genes that have significant hypermethylated promoters in very early RASF. Our data show that changes in DNA methylation differ in RASF compared to other forms of arthritis and occur at a very early, clinically yet unspecific stage of disease. The identified differential methylated genes might become valuable prognostic biomarkers for RA development.

Details

Original languageEnglish
Article number7370
JournalScientific Reports
Volume8
Issue number1
Publication statusPublished - 9 May 2018

ASJC Scopus subject areas